288 related articles for article (PubMed ID: 27836336)
41. Morphometric analysis of medial temporal lobe subregions in Alzheimer's disease using high-resolution MRI.
Hari E; Kurt E; Ulasoglu-Yildiz C; Bayram A; Bilgic B; Demiralp T; Gurvit H
Brain Struct Funct; 2023 Nov; 228(8):1885-1899. PubMed ID: 37486408
[TBL] [Abstract][Full Text] [Related]
42. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
43. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.
Jack CR; Petersen RC; Xu YC; Waring SC; O'Brien PC; Tangalos EG; Smith GE; Ivnik RJ; Kokmen E
Neurology; 1997 Sep; 49(3):786-94. PubMed ID: 9305341
[TBL] [Abstract][Full Text] [Related]
44. Association of Sleep-Disordered Breathing and Medial Temporal Lobe Atrophy in Cognitively Unimpaired Amyloid-Positive Older Adults.
André C; Kuhn E; Rehel S; Ourry V; Demeilliez-Servouin S; Palix C; Felisatti F; Champetier P; Dautricourt S; Yushkevich P; Vivien D; de La Sayette V; Chételat G; de Flores R; Rauchs G;
Neurology; 2023 Jul; 101(4):e370-e385. PubMed ID: 37258299
[TBL] [Abstract][Full Text] [Related]
45. Three-dimensional mapping of neurofibrillary tangle burden in the human medial temporal lobe.
Yushkevich PA; Muñoz López M; Iñiguez de Onzoño Martin MM; Ittyerah R; Lim S; Ravikumar S; Bedard ML; Pickup S; Liu W; Wang J; Hung LY; Lasserve J; Vergnet N; Xie L; Dong M; Cui S; McCollum L; Robinson JL; Schuck T; de Flores R; Grossman M; Tisdall MD; Prabhakaran K; Mizsei G; Das SR; Artacho-Pérula E; Arroyo Jiménez MDM; Marcos Raba MP; Molina Romero FJ; Cebada Sánchez S; Delgado González JC; de la Rosa-Prieto C; Córcoles Parada M; Lee EB; Trojanowski JQ; Ohm DT; Wisse LEM; Wolk DA; Irwin DJ; Insausti R
Brain; 2021 Oct; 144(9):2784-2797. PubMed ID: 34259858
[TBL] [Abstract][Full Text] [Related]
46. Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults.
Casaletto KB; Ward ME; Baker NS; Bettcher BM; Gelfand JM; Li Y; Chen R; Dutt S; Miller B; Kramer JH; Green AJ
Neurobiol Aging; 2017 Mar; 51():141-147. PubMed ID: 28068565
[TBL] [Abstract][Full Text] [Related]
47. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
de Flores R; Wisse LEM; Das SR; Xie L; McMillan CT; Trojanowski JQ; Robinson JL; Grossman M; Lee E; Irwin DJ; Yushkevich PA; Wolk DA
Alzheimers Dement; 2020 Jun; 16(6):843-852. PubMed ID: 32323446
[TBL] [Abstract][Full Text] [Related]
48. Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.
Eskildsen SF; Coupé P; Fonov VS; Pruessner JC; Collins DL;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S23-31. PubMed ID: 25260851
[TBL] [Abstract][Full Text] [Related]
49. Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.
Delgado-González JC; Florensa-Vila J; Mansilla-Legorburo F; Insausti R; Artacho-Pérula E
J Alzheimers Dis; 2017; 57(2):461-473. PubMed ID: 28269774
[TBL] [Abstract][Full Text] [Related]
50. How early can we predict Alzheimer's disease using computational anatomy?
Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
[TBL] [Abstract][Full Text] [Related]
51. Discrimination of normal aging, MCI and AD with multimodal imaging measures on the medial temporal lobe.
Jhoo JH; Lee DY; Choo IH; Seo EH; Oh JS; Lee JS; Lee DS; Kim SG; Youn JC; Kim KW; Woo JI
Psychiatry Res; 2010 Sep; 183(3):237-43. PubMed ID: 20705437
[TBL] [Abstract][Full Text] [Related]
52. Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Inuzuka T
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):126-131. PubMed ID: 27330118
[TBL] [Abstract][Full Text] [Related]
53. Disentangling normal aging from Alzheimer's disease in structural magnetic resonance images.
Lorenzi M; Pennec X; Frisoni GB; Ayache N;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S42-52. PubMed ID: 25311276
[TBL] [Abstract][Full Text] [Related]
54. Arterial stiffness and medial temporal lobe atrophy in elders with memory disorders.
Lilamand M; Vidal JS; Plichart M; De Jong LW; Duron E; Hanon O
J Hypertens; 2016 Jul; 34(7):1331-7. PubMed ID: 27136311
[TBL] [Abstract][Full Text] [Related]
55. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
[TBL] [Abstract][Full Text] [Related]
56. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
Boccardi M; Bocchetta M; Morency FC; Collins DL; Nishikawa M; Ganzola R; Grothe MJ; Wolf D; Redolfi A; Pievani M; Antelmi L; Fellgiebel A; Matsuda H; Teipel S; Duchesne S; Jack CR; Frisoni GB;
Alzheimers Dement; 2015 Feb; 11(2):175-83. PubMed ID: 25616957
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.
Teipel SJ; Pruessner JC; Faltraco F; Born C; Rocha-Unold M; Evans A; Möller HJ; Hampel H
J Neurol; 2006 Jun; 253(6):794-800. PubMed ID: 16511646
[TBL] [Abstract][Full Text] [Related]
58. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
Teipel S; Grothe MJ;
J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
[TBL] [Abstract][Full Text] [Related]
59. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
60. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
